Physician profile
Heather Axelrod
NPI 1700237500
$1,597.38
in general payments reported to CMS, 2019-2025
24 companies · $298 in 2025
The $298 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $140 · 2021: $146 · 2022: $209 · 2023: $165 · 2024: $343 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $412.08 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Tris Pharma INC | $195.40 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $176.80 | 2019-2024 | |
| Myovant Sciences INC. | $139.48 | 2021-2022 | |
| Pfizer INC. | $124.14 | 2020-2025 | |
| Sanofi Pasteur INC. | $68.93 | 2021-2025 | |
| Hologic Sales and Service, LLC | $47.62 | 2024 | Aptima |
| Therapeuticsmd, INC. | $38.83 | 2020-2022 | |
| Amarin Pharma, INC. | $37.08 | 2020 | |
| Seqirus USA INC | $34.72 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Exact Sciences Corporation | $33.44 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $33.23 | 2021-2022 | |
| Adlon Therapeutics L.P. | $32.74 | 2020 | |
| Sage Therapeutics, LLC | $32.35 | 2025 | Zurzuvae |
| Biogen, INC. | $24.07 | 2024 | Spinraza |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $23.38 | 2025 | Bexsero, Pediarix |
| Takeda Pharmaceuticals U.S.A., INC. | $21.77 | 2021 | |
| Collegium Pharmaceutical, INC. | $19.98 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $18.52 | 2025 | Qelbree |
| Corium, LLC | $18.22 | 2022 | |
| Nestle Healthcare Nutrition INC. | $17.52 | 2023 | |
| Kaleo, INC. | $17.00 | 2019 | |
| Idorsia Pharmaceuticals US INC | $15.60 | 2023 | Quviviq |
| Ultragenyx Pharmaceutical INC. | $14.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Axelrod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.